Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 737 across all filing types
Latest filing 2021-07-28 Regulatory Filings
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details changes to contract amounts, duration, and counterparty information. Since this is a specific regulatory disclosure of a material business event that does not fit into categories like earnings, dividends, or governance, it falls under the general regulatory filing category.
2021-07-28 Korean
투자판단관련주요경영사항(특허취득)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (Aprogen MED) regarding a 'major management matter' (투자판단 관련 주요경영사항), specifically the acquisition of a patent. Since this is a standard regulatory disclosure of a corporate event that does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-07-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including major shareholding notifications, changes in special relationships, and details of share-related contracts (like collateral). This falls under the 'Major Shareholding Notification' category.
2021-06-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an insider or major shareholder changes their stake in a listed company. This specific type of filing is categorized as a 'Major Shareholding Notification' (MRQ) as it details the change in ownership percentage and the specific transaction details (disposal of shares).
2021-06-29 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서). This type of filing is used to notify the market when a major shareholder or insider changes their stake in the company. According to the provided definitions, this falls under 'Major Shareholding Notification' (MRQ), as it details the change in ownership percentage and specific share counts for major shareholders.
2021-06-29 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details changes in share ownership by a major shareholder (G-BAISE Inc.) in the company Aprogen Medicines. This type of filing, which reports personal or entity-level share transactions by insiders or major shareholders, is classified as 'Director's Dealing' (DIRS) in the provided schema.
2021-06-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.